Sexually Transmitted Disease Surveillance 1998 Supplement: Gonococcal Isolate Surveillance Project (GISP) Annual Report – 1998

Wang, Susan A.

Advanced Search

Select up to three search categories and corresponding keywords using the fields to the right. Refer to the Help section for more detailed instructions.

Search our Collections & Repository

Advanced Search
Custom Query

All these words:

For very narrow results

This exact word or phrase:

When looking for a specific result

Any of these words:

Best used for discovery & interchangable words

None of these words:

Recommended to be used in conjunction with other fields

Language:

Dates

Publication Date Range:

to

Document Data

Title:

Document Type:

Library

Collection:

Series:

People

Author:

Clear All

Query Builder

Query box

Clear All

For additional assistance using the Custom Query please check out our Help Page

i

Sexually Transmitted Disease Surveillance 1998 Supplement: Gonococcal Isolate Surveillance Project (GISP) Annual Report – 1998

November 1999
By Wang, Susan A.

[PDF-766.14 KB]

English

Details You May Also Like

Details:

Alternative Title:

Gonococcal Isolate Surveillance Project (GISP) annual report, 1998;GISP 1998 surveillance supplement;
Personal Author:

Wang, Susan A.
Corporate Authors:

National Center for HIV, STD, and TB Prevention (U.S.). Division of STD Prevention.
Description:

"Gonorrhea is the second most frequently reported communicable disease in the United States. Overall gonorrhea rates in the United States declined 72% since 1975. However, between 1997 and 1998, the rate increased by 8.9% from 122.0 cases per 100,000 persons to 132.9. Gonorrhea rates remain high in the southeastern states, among minorities, and among adolescents of all racial and ethnic groups. The health impact of gonorrhea is largely related to its role as a major cause of pelvic inflammatory disease, which frequently leads to infertility or ectopic pregnancy.2 In addition, recent data suggest that gonorrhea facilitates HIV transmission. Control of gonorrhea has been complicated by the development of resistance to antimicrobial agents. The appearance of penicillinase-producing Neisseria gonorrhoeae (PPNG) and chromosomally mediated penicillin- and tetracycline-resistant N. gonorrhoeae (CMRNG) in the 1970s eventually led to the abandonment of these drugs as therapies for gonorrhea. The currently recommended primary therapies for gonorrhea are two broad-spectrum cephalosporins, ceftriaxone and cefixime, and two fluoroquinolones, ciprofloxacin and ofloxacin.5 However, fluoroquinolone-resistant N. gonorrhoeae have been reported from many parts of the world, including the United States." -- p. 1.
Content Notes:

Division of STD Prevention, prepared by Susan A. Wang, Jester Harvey, William C. Levine, Joan S. Knapp, David L. Trees, Manhar Parekh and Sandra W. Neal.

"November 1999."

Also available via the World Wide Web.

Includes bibliographical references (p. 5-6).
Subjects:

[+]

Gonorrhea Sexually Transmitted Diseases
Document Type:

Report
Name as Subject:

Gonococcal Isolate Surveillance Project (U.S.) ; Gonococcal Isolate Surveillance Project (U.S.)

Gonococcal Isolate Surveillance Project (U.S.) ; Gonococcal Isolate Surveillance Project (U.S.) Less -
Genre:

Statistics ; Annual Reports

Statistics ; Annual Reports Less -
Place as Subject:

United States
Collection(s):

Stephen B. Thacker CDC Library collection
Main Document Checksum:

[+]

urn:sha256:e4b3937659a2f5b2cd266fb43e2abaad988b10b5cb347257129e6c8cdbd1faea
Download URL:

https://stacks.cdc.gov/view/cdc/24428/cdc_24428_DS1.pdf
File Type:

No Additional Files

More +

Sexually Transmitted Disease Surveillance 1998 Supplement: Gonococcal Isolate Surveillance Project (GISP) Annual Report – 1998

Details:

Supporting Files

You May Also Like